Edge Pharma, LLC recalls Ceftazidime, Sterile Ophthalmic Solution for Injection, Preservative Free (11.25 mg/0.5 mL (22.5 mg/mL), 0.5mL single us
Recalled February 2, 2022 · FDA recall D-0397-2022 · Edge Pharma
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
168 syringes
Sold at
nationwide
Description
Lack of Assurance of Sterility
Product
Ceftazidime, Sterile Ophthalmic Solution for Injection, Preservative Free (11.25 mg/0.5 mL (22.5 mg/mL), 0.5mL single use syringe for Intraocular Injection, Edge Pharma, LLC, 656 Hercules Dr., Colchester, VT 05446, NDC 05446-0733-01
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →